Trial Profile
Chemoprevention trial using erlotinib in Barrett's esophagus with high-grade dysplasia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Barrett's oesophagus; Oesophageal cancer
- Focus Therapeutic Use